Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up
Overall Assessment |
Analysis |
Score |
None
|
No evidence found
View Sources
|
E
|
Overall Assessment |
Analysis |
Score |
Limited
|
Henry Schein provides only limited insight into its climate-related lobbying. The company states that it participates in sector initiatives such as the National Academy of Medicine’s Action Collaborative on Decarbonizing the U.S. Health Sector and the Healthcare Distribution Alliance Decarbonization Task Force, revealing an indirect mechanism of engagement, but it does not identify which government bodies or individual policymakers these coalitions seek to influence, nor does it describe other methods such as meetings, submissions, or correspondence. It offers no disclosure of any specific climate policies, regulations, or bills it has lobbied, leaving readers unable to determine the scope or focus of its advocacy. The company also speaks only in broad terms about wanting to meet its net-zero commitments and expand renewable energy sourcing, without spelling out concrete legislative changes, targets, or amendments it is pursuing. Taken together, the disclosure conveys a general intention to engage on decarbonisation but lacks the detail necessary to demonstrate meaningful transparency on the policies, lobbying channels, and outcomes sought.
|
D
|